BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World J Hepatol 2021; 13(12): 1828-1849 [PMID: 35069993 DOI: 10.4254/wjh.v13.i12.1828]
URL: https://www.wjgnet.com/1007-9327/full/v13/i12/1828.htm
Number Citing Articles
1
Nancy Gupta, Sam Papasotiriou, Stephen Hanauer. The evolving role of JAK inhibitors in the treatment of inflammatory bowel diseaseExpert Review of Clinical Immunology 2023; 19(9): 1075 doi: 10.1080/1744666X.2023.2214728
2
Milagros Miquilena, Cesar Morao, Yauribel Martínez, María Guerrero, Magaly Rodríguez G. Alteraciones hepatobiliares de la enfermedad inflamatoria intestinal en pediatríaRevista GEN 2024; 77(4): 167 doi: 10.61155/2023.77.4.004
3
Helgi K. Björnsson, Einar S. Björnsson. Hepatotoxicity in inflammatory bowel disease: Immunomodulators, biologics, and beyondClinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000199
4
Roberto Catanzaro, Francesco Marotta, Azam Yazdani, Morena Sciuto. Inflammatory Bowel Disease Therapies and Acute Liver InjuryToxics 2024; 12(6): 421 doi: 10.3390/toxics12060421
5
Rama HG Mikhail, Konstantinos Syrrakos, Rama HG Mikhail, Konstantinos Syrrakos. Acute cholecystitis as a complication of diverting loop ileostomy: A case series and narrative reviewJournal of Case Reports and Images in Surgery 2023; 9(2): 16 doi: 10.5348/100124Z12RM2023CS
6
Mohammad Amin Manavi, Mohammad Hosein Fathian Nasab, Razieh Mohammad Jafari, Ahmad Reza Dehpour. Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agentsJournal of Chemotherapy 2024; 36(8): 623 doi: 10.1080/1120009X.2023.2300217
7
Katharina Stratmann, Songül Aydolmus, Wenyi Gu, Dominik Heling, Ulrich Spengler, Birgit Terjung, Christian P. Strassburg, Richard Vollenberg, Irina Blumenstein, Jonel Trebicka. Hepatobiliary manifestations in patients with ulcerative colitis: a retrospective analysisFrontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1273797
8
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and TricksInflammatory Bowel Diseases 2023; 29(9): 1477 doi: 10.1093/ibd/izac189
9
Livia Moreira Genaro, Julian Furtado Silva, Luis Eduardo Miani Gomes, Hugo Dugolin Ceccato, Amanda Pereira Lima, Maria de Lourdes Setsuko Ayrizono, Marciane Milanski Ferreira, Raquel Franco Leal. Natural Plant Products in Inflammatory Bowel Diseases2023; : 47 doi: 10.1016/B978-0-323-99111-7.00013-1